Ardian-backed Laboratoires Anios expands with Inibsa Hospital

The acquisition marks the group's fourth acquisition under Ardian's ownership. The GP had invested in the French pharmaceutical company in a mid-market MBO in 2013, acquiring it from French multinational Air Liquide through its €2.41bn LBO Fund V. As a result of the transaction, the GP's management team and employees owned nearly half of the business.

Previous bolt-ons included Endoclear – a Brazilian company specialised in automatic endoscope disinfection processes – and Turkish group Deren last year, as well as the French business Soluscope in 2014.

This new bolt-on is in line with Ardian's intention to develop the group on an international scale. Anios's aim is to generate 50% of its turnover – currently sitting at €220m – outside France by 2020.

Company
Founded in 1948 in Barcelona, Inibsa Hospital is a Spanish pharmaceutical company specialising in disinfection. It manufactures and commercialises products for the odontology, hospital and pharmaceutical sectors.

The company registered a €7m turnover in 2015.

People
Ardian – Philippe Poletti (senior managing director).

Advisers
Equity – Grant Thornton (financial due diligence); Garrigues (legal).
Vendor – Deloitte (financial due diligence). 

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Portfolio management
• France
• Healthcare
• Southern Europe
• Ardian (formerly Axa PE)
• France
• Spain
• Build-up